The FDA warned about potentially fatal side effects of Invokana and other SGLT2 inhibitor drugs. Invokana lawyers filed lawsuits on behalf of people who say they these drugs injured them. SGLT2 inhibitors treat Type 2 diabetes but may trigger dangerous levels of blood acids and increase the risk of urinary tract infections. Studies also show they may increase the risk of stroke, heart attack and kidney problems that may require hospitalization.
What is Invokana (Canagliflozin)?
Invokana (canagliflozin) is one of several drugs that belong to a new class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Normally, when a person eats the body produces insulin to process sugar that enters the body. In people with Type 2 diabetes, this response no longer works the way it should, and they develop insulin resistance. Eventually, the pancreas canâ€™t keep up with the demand for insulin and sugar levels rise to dangerous levels. Invokana and other SGLT2 inhibitors prevent the kidneys from reabsorbing sugar and releasing it into the blood, however, not without side effects. Common serious side effects of Invokana include diabetic ketoacidosis, kidney injury, urinary tract infections and cardiovascular.